Stewart Cole

Stewart Cole is an internationally renowned scientist and professor of Microbial Pathogenesis. Since January 2^nd, 2018, he is the President of the Institut Pasteur.

From 2007 to 2017, he served as Professor and Director of the Global Health Institute at the Swiss Federal Institute of Technology (EPFL), a world-leading education and research center.

Cole worked as a researcher for 24 years and held various research management positions at the Institut Pasteur. He was Director of Strategic Technologies and then Executive Scientific Director, contributing to several patent applications relating to HIV/AIDS, cervical cancer, and multidrug-resistant tuberculosis. He participated in the Scientific Advisory Boards of the Institut Pasteur in Iran, the Institut Pasteur in Montevideo, and the Institut Pasteur in Lille. Professor Cole was also acting as President of the Institut Pasteur in Paris in 2005.

He has received many national and international prizes and distinctions. In 2009, he was awarded the World Health Organization’s prestigious “Stop-TB Partnership Kochon” prize for his leadership and groundbreaking accomplishments in genetic research on M. tuberculosis as well as his contribution to novel therapeutic strategies for tackling TB.

During his career, he has been involved in the work of several foundations and scientific committees, and was notably Chair of the board of the Innovative Medicine for Tuberculosis Foundation and the President of the Commission Médicale for the Fondation Raoul Follereau.

Stewart Cole has also published more than 350 scientific papers on infectious diseases, most notably tuberculosis and leprosy.